Free Submission Public Relations &
Deutsch English


SADIF Analytics upgraded ImmunoGen, Inc. to

Print article Print article
2013-03-11 14:20:23 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to ImmunoGen, Inc. and produced a Rating Update Report, rating the company's attractiveness to long-term investors.

Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering ImmunoGen, Inc. (IMGN). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential ImmunoGen, Inc. investor.

Report Summary: ImmunoGen, Inc. is a low quality company with a neutral outlook. ImmunoGen, Inc. has weak business growth and is run by inefficient management. The trend in ImmunoGen, Inc. fair value exchange rate against its closest rated-competitor, Ironwood Pharmaceuticals, Inc., has been depreciating over the past 2 weeks. When compared to its closest competitor, ImmunoGen, Inc. shows less overvaluation and is equally likely to underperform the market.

The 3-page report breaks down the Total StockMark into its three components – business, management and price,

performing an in-depth analysis of ImmunoGen, Inc. for long-term investors.

The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:

About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.

Contact Information:
SADIF-Investment Analytics

Rua Domingos F. Pinto Basto, 17
3830-176 Ilhavo, Portugal

Contact Person:
Antonio Mendes
Phone: ( 351) 234 322037
email: email


Antonio Mendes
Phone: (+351) 234 322 037

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact